KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.51.

  • Gilead Sciences' Asset Utilization Ratio fell 274.81% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year decrease of 274.81%. This contributed to the annual value of 0.47 for FY2024, which is 969.68% up from last year.
  • Per Gilead Sciences' latest filing, its Asset Utilization Ratio stood at 0.51 for Q3 2025, which was down 274.81% from 0.51 recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Asset Utilization Ratio ranged from a high of 0.52 in Q3 2024 and a low of 0.38 during Q1 2021
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.44 (2022), whereas its average is 0.45.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 1918.53% in 2024, then crashed by 274.81% in 2025.
  • Gilead Sciences' Asset Utilization Ratio (Quarter) stood at 0.4 in 2021, then increased by 7.32% to 0.43 in 2022, then grew by 0.38% to 0.44 in 2023, then increased by 16.3% to 0.51 in 2024, then increased by 0.51% to 0.51 in 2025.
  • Its Asset Utilization Ratio stands at 0.51 for Q3 2025, versus 0.51 for Q2 2025 and 0.5 for Q1 2025.